Evidence map›Paper›PMID 34432545›Full record

ReviewGut microbes

Teaching old mice new tricks: the utility of aged mouse models of C. difficile infection to study pathogenesis and rejuvenate immune response.

Jae Hyun Shin, Sean W Pawlowski, Cirle A Warren

Open access · goldAbstract readReview
In one paragraph

Review in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The state of play of rodent models for the study ofJournal of medical microbiology · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jae Hyun ShinDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA.
Sean W PawlowskiColorado Infectious Disease Associates, Denver, CO, USA.
Cirle A WarrenDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, USA.
University of Virginia · USInfectious Disease Consultants · US

Funding

Alanyl-glutamine supplementation of standard treatment for C. difficile infectionR01AI145322 · NIAID · UNIVERSITY OF VIRGINIA · PI WARREN, CIRLE ALCANTARA · 2020 to 2024
$4.0M
Aging and Clostridium difficile infection: interplay of microbiota and host responseK08AG064151 · NIA · UNIVERSITY OF VIRGINIA · PI SHIN, JAE HYUN · 2019 to 2023
$801k
NIAID NIH HHS R01 AI145322NIA NIH HHS K08 AG064151
6 · The paper itself

Abstract

background

methodsWe reviewed five published studies utilizing aged mice (7-28 months) for CDI model for findings that may advance our understanding of how aging influences outcome from CDI.

resultsAged mouse models of CDI uniformly demonstrated more severe disease in the old compared to young mice. Diminished neutrophil recruitment to intestinal tissue in aged mice is the most consistent finding. Differences in innate and humoral immune responses were also observed. The effects of aging on the outcome of infection were reversed by pharmacologic or microbiota-targeted interventions.

conclusionThe aged mouse presents an important in vivo model to study CDI and elucidate the mechanisms underlying advanced age as an important risk factor for severe disease.

Indexed as

AgingAnimalsClostridioides difficileDisease Models, AnimalEnterocolitis, PseudomembranousGastrointestinal MicrobiomeGerm-Free LifeIntestinal MucosaMiceNeutrophil InfiltrationNeutrophilsRisk FactorsSeverity of Illness IndexagingAnimal modelClostridioides difficile infectionmicrobiotaneutrophil response

Identifiers

PMID34432545
PMCPMC8405153
OpenAlexW3195687410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.